{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:56:00Z","timestamp":1793199360887,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Financial support was provided by the Research Agency of Ministry of Education, Research, Development and Youth of the Slovak Republic","award":["ITMS2014+: 313011V446"],"award-info":[{"award-number":["ITMS2014+: 313011V446"]}]},{"name":"Financial support was provided by the Research Agency of Ministry of Education, Research, Development and Youth of the Slovak Republic","award":["ITMS2014+: 313011V446"],"award-info":[{"award-number":["ITMS2014+: 313011V446"]}]},{"name":"Financial support was provided by the Research Agency of Ministry of Education, Research, Development and Youth of the Slovak Republic","award":["ITMS2014+: 313011V446"],"award-info":[{"award-number":["ITMS2014+: 313011V446"]}]},{"name":"Financial support was provided by the Research Agency of Ministry of Education, Research, Development and Youth of the Slovak Republic","award":["ITMS2014+: 313011V446"],"award-info":[{"award-number":["ITMS2014+: 313011V446"]}]},{"name":"Financial support was provided by the Research Agency of Ministry of Education, Research, Development and Youth of the Slovak Republic","award":["ITMS2014+: 313011V446"],"award-info":[{"award-number":["ITMS2014+: 313011V446"]}]},{"name":"Financial support was provided by the Research Agency of Ministry of Education, Research, Development and Youth of the Slovak Republic","award":["ITMS2014+: 313011V446"],"award-info":[{"award-number":["ITMS2014+: 313011V446"]}]},{"name":"Slovak Research and Development Agency of Ministry of Education, Research, Development and Youth of the Slovak Republic","award":["APVV-19-0476"],"award-info":[{"award-number":["APVV-19-0476"]}]},{"name":"Slovak Research and Development Agency of Ministry of Education, Research, Development and Youth of the Slovak Republic","award":["APVV-19-0476"],"award-info":[{"award-number":["APVV-19-0476"]}]},{"name":"Slovak Research and Development Agency of Ministry of Education, Research, Development and Youth of the Slovak Republic","award":["APVV-19-0476"],"award-info":[{"award-number":["APVV-19-0476"]}]},{"name":"Slovak Research and Development Agency of Ministry of Education, Research, Development and Youth of the Slovak Republic","award":["APVV-19-0476"],"award-info":[{"award-number":["APVV-19-0476"]}]},{"name":"Slovak Research and Development Agency of Ministry of Education, Research, Development and Youth of the Slovak Republic","award":["APVV-19-0476"],"award-info":[{"award-number":["APVV-19-0476"]}]},{"name":"Slovak Research and Development Agency of Ministry of Education, Research, Development and Youth of the Slovak Republic","award":["APVV-19-0476"],"award-info":[{"award-number":["APVV-19-0476"]}]},{"name":"Scientific Grant Agency of Ministry of Education, Research, Development and Youth of the Slovak Republic and Slovak Academy of Sciences","award":["VEGA 1\/0582\/25"],"award-info":[{"award-number":["VEGA 1\/0582\/25"]}]},{"name":"Scientific Grant Agency of Ministry of Education, Research, Development and Youth of the Slovak Republic and Slovak Academy of Sciences","award":["VEGA 1\/0582\/25"],"award-info":[{"award-number":["VEGA 1\/0582\/25"]}]},{"name":"Scientific Grant Agency of Ministry of Education, Research, Development and Youth of the Slovak Republic and Slovak Academy of Sciences","award":["VEGA 1\/0582\/25"],"award-info":[{"award-number":["VEGA 1\/0582\/25"]}]},{"name":"Scientific Grant Agency of Ministry of Education, Research, Development and Youth of the Slovak Republic and Slovak Academy of Sciences","award":["VEGA 1\/0582\/25"],"award-info":[{"award-number":["VEGA 1\/0582\/25"]}]},{"name":"Scientific Grant Agency of Ministry of Education, Research, Development and Youth of the Slovak Republic and Slovak Academy of Sciences","award":["VEGA 1\/0582\/25"],"award-info":[{"award-number":["VEGA 1\/0582\/25"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-39686-y","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:49:14Z","timestamp":1770695354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Peripheral blood CD14\u2009+\u2009monocytes in luminal breast carcinoma subtypes: in preliminary research and overview of candidate biomarker proteins"],"prefix":"10.1038","volume":"16","author":[{"given":"Michal","family":"Alexovi\u010d","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Marcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Parnica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Marcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Len\u00e1rt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e1vid","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Rado\u0148ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Urdz\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1n","family":"Sabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"39686_CR1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/cge.13900","volume":"99","author":"A Szymiczek","year":"2021","unstructured":"Szymiczek, A., Lone, A. & Akbari, M. R. Molecular intrinsic versus clinical subtyping in breast cancer: A comprehensive review. Clin. Genet. 99, 613\u2013637 (2021).","journal-title":"Clin. Genet."},{"key":"39686_CR2","doi-asserted-by":"publisher","first-page":"110776","DOI":"10.1016\/j.clinbiochem.2024.110776","volume":"129","author":"CJ Vellan","year":"2024","unstructured":"Vellan, C. J. et al. Exploring novel protein-based biomarkers for advancing breast cancer diagnosis: A review. Clin. Biochem. 129, 110776 (2024).","journal-title":"Clin. Biochem."},{"key":"39686_CR3","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch, A. et al. Strategies for subtypes\u2013dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann. Oncol. 22, 1736\u20131747 (2011).","journal-title":"Ann. Oncol."},{"key":"39686_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/JLB.4RI0818-311R","volume":"106","author":"CE Olingy","year":"2019","unstructured":"Olingy, C. E., Dinh, H. Q. & Hedrick, C. C. Monocyte heterogeneity and functions in cancer. J. Leukoc. Biol. 106, 309\u2013322 (2019).","journal-title":"J. Leukoc. Biol."},{"key":"39686_CR5","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1038\/s41598-020-61356-w","volume":"10","author":"BJ Ravenhill","year":"2020","unstructured":"Ravenhill, B. J., Soday, L., Houghton, J., Antrobus, R. & Weekes, M. P. Comprehensive cell surface proteomics defines markers of classical, intermediate and non-classical monocytes. Sci. Rep. 10, 4560 (2020).","journal-title":"Sci. Rep."},{"key":"39686_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12014-024-09463-y","volume":"21","author":"Y Jeon","year":"2024","unstructured":"Jeon, Y. et al. Proteomic analysis of breast cancer based on immune subtypes. Clin. Proteom. 21, 17 (2024).","journal-title":"Clin. Proteom."},{"key":"39686_CR7","doi-asserted-by":"publisher","first-page":"6423","DOI":"10.3390\/ijms25126423","volume":"25","author":"M Len\u00e1rt","year":"2024","unstructured":"Len\u00e1rt, M. et al. Peripheral blood CD8\u2009+\u2009T-Lymphocyte immune response in benign and subpopulations of breast cancer patients. Int. J. Mol. Sci. 25, 6423 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"39686_CR8","doi-asserted-by":"publisher","first-page":"7351","DOI":"10.3390\/ijms25137351","volume":"25","author":"S Tk\u00e1\u010dikov\u00e1","year":"2024","unstructured":"Tk\u00e1\u010dikov\u00e1, S. et al. B cell lymphocytes as a potential source of breast carcinoma marker candidates. Int. J. Mol. Sci. 25, 7351 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"39686_CR9","unstructured":"Singh, B. C. R. & Protein Clinical Relevance and Interpretation. in StatPearls (StatPearls Publishing)."},{"key":"39686_CR10","first-page":"CD011811","volume":"4","author":"D Molano Franco","year":"2019","unstructured":"Molano Franco, D. et al. Plasma interleukin-6 concentration for the diagnosis of sepsis in critically ill adults. Cochrane Database Syst. Rev. 4, CD011811 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"39686_CR11","doi-asserted-by":"publisher","first-page":"e1001216","DOI":"10.1371\/journal.pmed.1001216","volume":"9","author":"DG Altman","year":"2012","unstructured":"Altman, D. G., McShane, L. M., Sauerbrei, W. & Taube, S. E. Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. PLoS Med. 9, e1001216 (2012).","journal-title":"PLoS Med."},{"key":"39686_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"39686_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell. Syst. 1, 417\u2013425 (2015).","journal-title":"Cell. Syst."},{"key":"39686_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.it.2020.12.001","volume":"42","author":"A Robinson","year":"2021","unstructured":"Robinson, A., Han, C. Z., Glass, C. K. & Pollard, J. W. Monocyte regulation in homeostasis and malignancy. Trends Immunol. 42, 104\u2013119 (2021).","journal-title":"Trends Immunol."},{"key":"39686_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1146\/annurev-pathmechdis-012418-013058","volume":"16","author":"S Ugel","year":"2021","unstructured":"Ugel, S., Can\u00e8, S., De Sanctis, F. & Bronte, V. Monocytes in the tumor microenvironment. Annu. Rev. Pathol. 16, 93\u2013122 (2021).","journal-title":"Annu. Rev. Pathol."},{"key":"39686_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.molcel.2015.09.005","volume":"60","author":"O Anczuk\u00f3w","year":"2015","unstructured":"Anczuk\u00f3w, O. et al. SRSF1-Regulated alternative splicing in breast cancer. Mol. Cell. 60, 105\u2013117 (2015).","journal-title":"Mol. Cell."},{"key":"39686_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13046-021-01978-8","volume":"40","author":"JX Du","year":"2021","unstructured":"Du, J. X. et al. Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1. J. Exp. Clin. Cancer Res. 40, 171 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"39686_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41392-024-02118-2","volume":"10","author":"GQ Zhu","year":"2025","unstructured":"Zhu, G. Q. et al. Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8\u2009+\u2009T and tumor cells. Signal. Transduct. Target. Ther. 10, 25 (2025).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"39686_CR19","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.febslet.2014.01.015","volume":"588","author":"K Maher","year":"2014","unstructured":"Maher, K. et al. Decreased IL-10 expression in stefin B-deficient macrophages is regulated by the MAP kinase and STAT-3 signaling pathways. FEBS Lett. 588, 720\u2013726 (2014).","journal-title":"FEBS Lett."},{"key":"39686_CR20","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1038\/onc.2013.314","volume":"33","author":"M Butinar","year":"2014","unstructured":"Butinar, M. et al. Stefin B deficiency reduces tumor growth via sensitization of tumor cells to oxidative stress in a breast cancer model. Oncogene 33, 3392\u20133400 (2014).","journal-title":"Oncogene"},{"key":"39686_CR21","doi-asserted-by":"publisher","first-page":"e15099","DOI":"10.7717\/peerj.15099","volume":"11","author":"I Takan","year":"2023","unstructured":"Takan, I., Karak\u00fclah, G., Louka, A. & Pavlopoulou, A. In the light of evolution:\u2019 keratins as exceptional tumor biomarkers. PeerJ 11, e15099 (2023).","journal-title":"PeerJ"},{"key":"39686_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13058-023-01644-1","volume":"25","author":"S Lee","year":"2023","unstructured":"Lee, S. et al. Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2\/HER2-enriched breast cancer. Breast Cancer Res. 25, 46 (2023).","journal-title":"Breast Cancer Res."},{"key":"39686_CR23","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1007\/s12094-020-02354-2","volume":"22","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. & Luo, G. Apolipoproteins, as the carrier proteins for lipids, are involved in the development of breast cancer. Clin. Transl Oncol. 22, 1952\u20131962 (2020).","journal-title":"Clin. Transl Oncol."},{"key":"39686_CR24","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.2147\/CMAR.S191352","volume":"11","author":"JX Liu","year":"2019","unstructured":"Liu, J. X. et al. Apolipoprotein A1 and B as risk factors for development of intraocular metastasis in patients with breast cancer. Cancer Manag Res. 11, 2881\u20132888 (2019).","journal-title":"Cancer Manag Res."},{"key":"39686_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s40001-022-00784-y","volume":"27","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. The association between serum lipid levels and histological type of breast cancer. Eur. J. Med. Res. 27, 154 (2022).","journal-title":"Eur. J. Med. Res."},{"key":"39686_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4143\/crt.2012.44.2.121","volume":"44","author":"M Saadat","year":"2012","unstructured":"Saadat, M. Apolipoprotein E (APOE) polymorphisms and susceptibility to breast cancer: A Meta-Analysis. Cancer Res. Treat. 44, 121\u2013126 (2012).","journal-title":"Cancer Res. Treat."},{"key":"39686_CR27","doi-asserted-by":"publisher","first-page":"48635","DOI":"10.1074\/jbc.M208877200","volume":"277","author":"VP Yakubenko","year":"2002","unstructured":"Yakubenko, V. P., Lishko, V. K., Lam, S. C. T. & Ugarova, T. P. A molecular basis for integrin AlphaMbeta 2 ligand binding promiscuity. J. Biol. Chem. 277, 48635\u201348642 (2002).","journal-title":"J. Biol. Chem."},{"key":"39686_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13058-020-01373-9","volume":"22","author":"C Fredolini","year":"2020","unstructured":"Fredolini, C. et al. Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection. Breast Cancer Res. 22, 135 (2020).","journal-title":"Breast Cancer Res."},{"key":"39686_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2147\/JIR.S396321","volume":"16","author":"YY Shi","year":"2023","unstructured":"Shi, Y. Y. et al. Association of Enolase-1 with prognosis and immune infiltration in breast cancer by clinical stage. J. Inflamm. Res. 16, 493\u2013503 (2023).","journal-title":"J. Inflamm. Res."},{"key":"39686_CR30","doi-asserted-by":"publisher","first-page":"117822342412856","DOI":"10.1177\/11782234241285648","volume":"18","author":"A Giannoudis","year":"2024","unstructured":"Giannoudis, A., Heath, A. & Sharma, V. ENO1 as a biomarker of breast cancer progression and metastasis: A bioinformatic approach using available databases. Breast Cancer (Auckl). 18, 11782234241285648 (2024).","journal-title":"Breast Cancer (Auckl)"},{"key":"39686_CR31","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1021\/acs.molpharmaceut.6b00652","volume":"14","author":"R Soudy","year":"2017","unstructured":"Soudy, R., Etayash, H., Bahadorani, K., Lavasanifar, A. & Kaur, K. Breast cancer targeting peptide binds keratin 1: A new molecular marker for targeted drug delivery to breast cancer. Mol. Pharm. 14, 593\u2013604 (2017).","journal-title":"Mol. Pharm."},{"key":"39686_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13046-021-02223-y","volume":"41","author":"DV Pham","year":"2022","unstructured":"Pham, D. V. & Park, P. H. Adiponectin triggers breast cancer cell death via fatty acid metabolic reprogramming. J. Exp. Clin. Cancer Res. 41, 9 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"39686_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fendo.2020.00066","volume":"11","author":"GD Naimo","year":"2020","unstructured":"Naimo, G. D., Gelsomino, L., Catalano, S., Mauro, L. & And\u00f2, S. Interfering role of ER\u03b1 on adiponectin action in breast cancer. Front. Endocrinol. (Lausanne). 11, 66 (2020).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"39686_CR34","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13046-019-1221-0","volume":"38","author":"SI Al-Juboori","year":"2019","unstructured":"Al-Juboori, S. I. et al. PYK2 promotes HER2-positive breast cancer invasion. J. Exp. Clin. Cancer Res. 38, 210 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"39686_CR35","first-page":"1036","volume":"62","author":"A Chen","year":"2002","unstructured":"Chen, A. et al. Two forms of gonadotropin-releasing hormone (GnRH) are expressed in human breast tissue and overexpressed in breast cancer: a putative mechanism for the antiproliferative effect of GnRH by down-regulation of acidic ribosomal phosphoproteins P1 and P2. Cancer Res. 62, 1036\u20131044 (2002).","journal-title":"Cancer Res."},{"key":"39686_CR36","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1002\/jcp.30077","volume":"236","author":"S Okitsu-Sakurayama","year":"2021","unstructured":"Okitsu-Sakurayama, S., Higa-Nakamine, S., Torihara, H., Higashiyama, S. & Yamamoto, H. Roles of Pyk2 in signal transduction after gonadotropin-releasing hormone receptor stimulation. J. Cell. Physiol. 236, 3033\u20133043 (2021).","journal-title":"J. Cell. Physiol."},{"key":"39686_CR37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12885-022-09410-w","volume":"22","author":"B Han","year":"2022","unstructured":"Han, B., Zhen, F., Zheng, X. S., Hu, J. & Chen, X. S. Systematic analysis of the expression and prognostic value of ITPR1 and correlation with tumor infiltrating immune cells in breast cancer. BMC Cancer. 22, 297 (2022).","journal-title":"BMC Cancer"},{"key":"39686_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/BF03343685","volume":"23","author":"A Paradiso","year":"2000","unstructured":"Paradiso, A. et al. GnRH receptors in human breast cancer and its contiguous not-involved breast tissue. J. Endocrinol. Invest. 23, 90\u201396 (2000).","journal-title":"J. Endocrinol. Invest."},{"key":"39686_CR39","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s12094-019-02042-w","volume":"21","author":"X Jin","year":"2019","unstructured":"Jin, X. et al. Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K\/AKT\/Snail1\/E-cadherin axis. Clin. Transl Oncol. 21, 1207\u20131219 (2019).","journal-title":"Clin. Transl Oncol."},{"key":"39686_CR40","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1093\/carcin\/bgm078","volume":"28","author":"V Bertagnolo","year":"2007","unstructured":"Bertagnolo, V. et al. Phospholipase C-beta 2 promotes mitosis and migration of human breast cancer-derived cells. Carcinogenesis 28, 1638\u20131645 (2007).","journal-title":"Carcinogenesis"},{"key":"39686_CR41","doi-asserted-by":"publisher","first-page":"100905","DOI":"10.1016\/j.jbc.2021.100905","volume":"297","author":"JT Jackson","year":"2021","unstructured":"Jackson, J. T., Mulazzani, E., Nutt, S. L. & Masters, S. L. The role of PLC\u03b32 in immunological disorders, cancer, and neurodegeneration. J. Biol. Chem. 297, 100905 (2021).","journal-title":"J. Biol. Chem."},{"key":"39686_CR42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13058-015-0625-9","volume":"17","author":"A Rudolph","year":"2015","unstructured":"Rudolph, A. et al. A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density. Breast Cancer Res. 17, 110 (2015).","journal-title":"Breast Cancer Res."},{"key":"39686_CR43","doi-asserted-by":"publisher","first-page":"1152458","DOI":"10.3389\/fonc.2023.1152458","volume":"13","author":"A Torres-Sanchez","year":"2023","unstructured":"Torres-Sanchez, A. et al. Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models. Front. Oncol. 13, 1152458 (2023).","journal-title":"Front. Oncol."},{"key":"39686_CR44","doi-asserted-by":"publisher","first-page":"BSR20200869","DOI":"10.1042\/BSR20200869","volume":"41","author":"Z Lin","year":"2021","unstructured":"Lin, Z., Peng, R., Sun, Y., Zhang, L. & Zhang, Z. Identification of ribosomal protein family in triple-negative breast cancer by bioinformatics analysis. Biosci. Rep. 41, BSR20200869 (2021).","journal-title":"Biosci. Rep."},{"key":"39686_CR45","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1126\/science.aay0939","volume":"367","author":"RY Ebright","year":"2020","unstructured":"Ebright, R. Y. et al. Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis. Science 367, 1468\u20131473 (2020).","journal-title":"Science"},{"key":"39686_CR46","doi-asserted-by":"publisher","first-page":"107746","DOI":"10.1016\/j.compbiolchem.2022.107746","volume":"100","author":"ALK Azevedo","year":"2022","unstructured":"Azevedo, A. L. K. et al. Comprehensive analysis of the large and small ribosomal proteins in breast cancer: insights on proteomic and transcriptomic expression patterns, regulation, mutational landscape, and prognostic significance. Comput. Biol. Chem. 100, 107746 (2022).","journal-title":"Comput. Biol. Chem."},{"key":"39686_CR47","doi-asserted-by":"publisher","first-page":"1325452","DOI":"10.3389\/fonc.2023.1325452","volume":"13","author":"H Su","year":"2023","unstructured":"Su, H. et al. Establishment of a lysosome-related prognostic signature in breast cancer to predict immune infiltration and therapy response. Front. Oncol. 13, 1325452 (2023).","journal-title":"Front. Oncol."},{"key":"39686_CR48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/cjp2.309","volume":"9","author":"Y Chen","year":"2023","unstructured":"Chen, Y., Klingen, T. A., Aas, H., Wik, E. & Akslen, L. A. CD47 and CD68 expression in breast cancer is associated with tumor-infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis. J. Pathol. Clin. Res. 9, 151\u2013164 (2023).","journal-title":"J. Pathol. Clin. Res."},{"key":"39686_CR49","doi-asserted-by":"publisher","first-page":"32731","DOI":"10.1074\/jbc.M113.503771","volume":"288","author":"J Capecci","year":"2013","unstructured":"Capecci, J. & Forgac, M. The function of vacuolar ATPase (V-ATPase) a subunit isoforms in invasiveness of MCF10a and MCF10CA1a human breast cancer cells. J. Biol. Chem. 288, 32731\u201332741 (2013).","journal-title":"J. Biol. Chem."},{"key":"39686_CR50","doi-asserted-by":"publisher","first-page":"15228","DOI":"10.18632\/oncotarget.24445","volume":"9","author":"S Bonin","year":"2018","unstructured":"Bonin, S. et al. Reduced expression of \u03b1-L-Fucosidase-1 (FUCA-1) predicts recurrence and shorter cancer specific survival in luminal B LN+ breast cancer patients. Oncotarget 9, 15228\u201315238 (2018).","journal-title":"Oncotarget"},{"key":"39686_CR51","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.3892\/ol.2017.6757","volume":"14","author":"Q Wang","year":"2017","unstructured":"Wang, Q. et al. LAMP1 expression is associated with poor prognosis in breast cancer. Oncol. Lett. 14, 4729\u20134735 (2017).","journal-title":"Oncol. Lett."},{"key":"39686_CR52","doi-asserted-by":"publisher","first-page":"e91407","DOI":"10.1371\/journal.pone.0091407","volume":"9","author":"G Mountzios","year":"2014","unstructured":"Mountzios, G. et al. Differential expression of the insulin-like growth factor receptor among early breast cancer subtypes. PLoS One. 9, e91407 (2014).","journal-title":"PLoS One"},{"key":"39686_CR53","doi-asserted-by":"publisher","first-page":"8127","DOI":"10.3390\/ijms21218127","volume":"21","author":"A Schulze","year":"2020","unstructured":"Schulze, A., Oshi, M., Endo, I. & Takabe, K. MYC targets scores are associated with cancer aggressiveness and poor survival in ER-Positive primary and metastatic breast cancer. Int. J. Mol. Sci. 21, 8127 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"39686_CR54","doi-asserted-by":"crossref","unstructured":"Issac, M. S. M., Yousef, E., Tahir, M. R. & Gaboury, L. A. MCM2, MCM4, and MCM6 in Breast Cancer: Clinical Utility in Diagnosis and Prognosis. Neoplasia 21, 1015\u20131035 (2019).","DOI":"10.1016\/j.neo.2019.07.011"},{"key":"39686_CR55","doi-asserted-by":"publisher","first-page":"731528","DOI":"10.3389\/fonc.2022.731528","volume":"12","author":"S Chen","year":"2022","unstructured":"Chen, S. et al. Nucleolar and Coiled-Body phosphoprotein 1 is associated with stemness and represents a potential therapeutic target in Triple-Negative breast cancer. Front. Oncol. 12, 731528 (2022).","journal-title":"Front. Oncol."},{"key":"39686_CR56","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1158\/1538-7445.AM2023-1238","volume":"83","author":"MG Khodary","year":"2023","unstructured":"Khodary, M. G., Yirsaw, A. W., Samuel, T., Yates, C. & Bedi, D. Loss of HSPD1 induces cellular plasticity in triple-negative breast cancer cells. Cancer Res. 83, 1238 (2023).","journal-title":"Cancer Res."}],"updated-by":[{"DOI":"10.1038\/s41598-026-58367-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39686-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39686-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39686-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T07:03:18Z","timestamp":1783407798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39686-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39686"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39686-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-58367-4","URL":"https:\/\/doi.org\/10.1038\/s41598-026-58367-4","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all subjects involved in the study.Statement.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by Ethics Committee of Medical Faculty UPJ\u0160, protocol code 9 N\/2021, date of approval 17 June 2021, Ethics Committee of L. Pasteur University Hospital code 2020\/EK\/06047, date of approval 25 June 2020, and Ethics Committee of East Slovakian Institute of Oncology, protocol code EK\/1\/06\/2020, date of approval 1 June 2020.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}],"article-number":"8090"}}